Tom O'Brien Email

VP, Head Quality . GeoVax

Current Roles

Employees:
32
Revenue:
$2.5M
About
GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining regulatory approval of these vaccines in the USA and specified international markets. Outstanding preclinical results: GeoVax DNA/MVA vaccine protected 96% of non-human primates for over 3½ yrs. To our knowledge, this level of protection has not been achieved by other candidate vaccines.
GeoVax Address
1900 Lake Park Drive
Smyrna, GA
United States
GeoVax Email

Past Companies

GeoVax Labs, Inc.Vice President, Head of Quality
Sleath modeQuality Consultant
Vedanta Biosciences, Inc.Head of Quality

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.